PSYCHEDELICS IN EUROPE: REGULATORY PERSPECTIVE AND THERAPEUTIC POTENTIAL
🗣Gitte Moos Knudsen, Professor at University of Copenhagen, Lionel Thelen, Scientific Officer in the European Research Council, and Marion Haberkamp, European Medicines Agency
⏰Thu 6th July, 8PM CEST (7PM GMT, 2PM EST, 11AM PST)
📍Online (OPEN Community Platform)
Join us for an informative panel discussion on the regulatory perspective and therapeutic potential of psychedelics in Europe.
Moos Knudsen, a Professor at the University of Copenhagen, will provide insight into current research efforts and developments surrounding the therapeutic potential of psychedelic compounds. Lionel Thelen, Scientific Officer in the European Research Council, will discuss the challenges and opportunities related to psychedelic research and regulation in the EU. Marion Haberkamp, representing the European Medicines Agency, will provide an overview of the regulatory framework surrounding the use of psychedelics in therapeutic contexts.
Together, our distinguished panel will engage in a dynamic discussion, sharing their insights and expertise on the evolving field of psychedelic therapy and its potential impact on mental health treatment. Attendees will have the opportunity to learn about the latest developments in research, gain a greater understanding of the regulatory landscape, and explore the potential benefits of psychedelic-assisted therapy in Europe.